Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

August 1, 2016; Volume 57,Issue 8

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 8A;

SNMMI Newsline

  • You have access
    FDA Approves 18F-Fluciclovine and 68Ga-DOTATATE Products
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 9N;
  • You have access
    Foundation Opens $2-Million Competition for Alpha-Synuclein PET Tracer
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 10N;
  • You have access
    2016 SNMMI Image of the Year
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 11N;
  • You have access
    New Officers for SNMMI and SNMMI-TS
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 12N-14N;
  • You have access
    SNMMI Creates Fellowship Status; First Fellows Announced
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 14N;
  • You have access
    2016 Cassen Prize Awarded to Strauss
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 15N;
  • You have access
    McDougall Receives 2016 de Hevesy Award
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 15N-16N;
  • You have access
    Conti Recognized with Aebersold Award
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 16N-20N;
  • You have access
    O’Donoghue Recognized with Loevinger–Berman Award
    George Sgouros; on behalf of the SNMMI Medical Internal Radiation Dose Committee
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 17N;
  • You have access
    SNMMI Leadership Update: SNMMI 2016 Annual Meeting: A Time of Celebration, Learning, and Focus on the Future
    Virginia Pappas
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 18N;
  • You have access
    Science Briefs from the SNMMI Annual Meeting
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 19N-20N;

Editorials

  • You have access
    How to Achieve Approval of Radiolabeled-PSMA Diagnostic and Therapeutic Agents
    Michael M. Graham
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1159-1160; DOI: https://doi.org/10.2967/jnumed.116.175950

Focus on Molecular Imaging

  • You have access
    Molecular Imaging of Inflammation: Current Status
    Dima A. Hammoud
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1161-1165; DOI: https://doi.org/10.2967/jnumed.115.161182

Invited Perspectives

  • You have access
    A Comparison of Near-Infrared Diffuse Optical Imaging and 18F-FDG PET/CT for the Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy
    Shudong Jiang and Brian W. Pogue
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1166-1167; DOI: https://doi.org/10.2967/jnumed.116.174367
  • You have access
    PET Amyloid Analyses
    Kirk A. Frey and Robert A. Koeppe
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1168-1169; DOI: https://doi.org/10.2967/jnumed.116.173989

Clinical Investigations

  • You have access
    PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
    Clemens Kratochwil, Frederik L. Giesel, Melsa Stefanova, Martina Benešová, Marcus Bronzel, Ali Afshar-Oromieh, Walter Mier, Matthias Eder, Klaus Kopka and Uwe Haberkorn
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1170-1176; DOI: https://doi.org/10.2967/jnumed.115.171397
  • You have access
    Serial 18F-FET PET Imaging of Primarily 18F-FET–Negative Glioma: Does It Make Sense?
    Marcus Unterrainer, Florian Schweisthal, Bogdana Suchorska, Vera Wenter, Christine Schmid-Tannwald, Wolfgang P. Fendler, Ulrich Schüller, Peter Bartenstein, Jörg-Christian Tonn and Nathalie L. Albert
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1177-1182; DOI: https://doi.org/10.2967/jnumed.115.171033
  • You have access
    The Prognostic Impact of Early Change in 18F-FDG PET SUV After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer
    Hak Woo Lee, Hak Min Lee, Sung-Eun Choi, Hanna Yoo, Sung Gwe Ahn, Min Kyung Lee, Joon Jeong and Woo-Hee Jung
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1183-1188; DOI: https://doi.org/10.2967/jnumed.115.166322
  • You have access
    Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT
    Shigeto Ueda, Nobuko Yoshizawa, Takashi Shigekawa, Hideki Takeuchi, Hiroyuki Ogura, Akihiko Osaki, Toshiaki Saeki, Yukio Ueda, Tomohiko Yamane, Ichiei Kuji and Harumi Sakahara
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1189-1195; DOI: https://doi.org/10.2967/jnumed.115.167320
  • You have access
    99mTc-Glu-c(RGDyK)-Bombesin SPECT Can Reduce Unnecessary Biopsy of Masses That Are BI-RADS Category 4 on Ultrasonography
    Tiefeng Ji, Shi Gao, Zhaofei Liu, Hua Xing, Guoqing Zhao and Qingjie Ma
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1196-1200; DOI: https://doi.org/10.2967/jnumed.115.168773
  • You have access
    Assessment of Minimum 124I Activity Required in Uptake Measurements Before Radioiodine Therapy for Benign Thyroid Diseases
    Anja S. Gabler, Christian Kühnel, Thomas Winkens and Martin Freesmeyer
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1201-1206; DOI: https://doi.org/10.2967/jnumed.115.171066
  • You have access
    Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors
    Suraiya R. Dubash, Nicholas Keat, Paola Mapelli, Frazer Twyman, Laurence Carroll, Kasia Kozlowski, Adil Al-Nahhas, Azeem Saleem, Mickael Huiban, Ryan Janisch, Andrea Frilling, Rohini Sharma and Eric O. Aboagye
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1207-1213; DOI: https://doi.org/10.2967/jnumed.115.169532
  • You have access
    Clinical Evaluation of 99mTc-Rituximab for Sentinel Lymph Node Mapping in Breast Cancer Patients
    Nan Li, Xuejuan Wang, Baohe Lin, Hua Zhu, Cheng Liu, Xiaobao Xu, Yan Zhang, Shizhen Zhai, Tao OuYang, Jinfeng Li and Zhi Yang
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1214-1220; DOI: https://doi.org/10.2967/jnumed.115.160572
  • You have access
    Supraclavicular Brown Adipose Tissue 18F-FDG Uptake and Cardiovascular Disease
    Richard A.P. Takx, Amorina Ishai, Quynh A. Truong, Meghan H. MacNabb, Marielle Scherrer-Crosbie and Ahmed Tawakol
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1221-1225; DOI: https://doi.org/10.2967/jnumed.115.166025
  • You have access
    Quantitative Analysis of Dynamic 123I-mIBG SPECT Imaging Data in Healthy Humans with a Population-Based Metabolite Correction Method
    Jing Wu, Shu-fei Lin, Jean-Dominique Gallezot, Chung Chan, Rameshwar Prasad, Stephanie L. Thorn, Mitchel R. Stacy, Yiyun Huang, Taraneh Hashemi Zonouz, Yi-Hwa Liu, Rachel J. Lampert, Richard E. Carson, Albert J. Sinusas and Chi Liu
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1226-1232; DOI: https://doi.org/10.2967/jnumed.115.171710
  • You have access
    Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale
    Christopher C. Rowe, Gareth Jones, Vincent Doré, Svetlana Pejoska, Laura Margison, Rachel S. Mulligan, J. Gordon Chan, Kenneth Young and Victor L. Villemagne
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1233-1237; DOI: https://doi.org/10.2967/jnumed.115.171595
  • You have access
    Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis
    Donatienne Van Weehaeghe, Jenny Ceccarini, Aline Delva, Wim Robberecht, Philip Van Damme and Koen Van Laere
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1238-1243; DOI: https://doi.org/10.2967/jnumed.115.166272
  • You have access
    89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel–Lindau Disease
    Sjoukje F. Oosting, Sophie J. van Asselt, Adrienne H. Brouwers, Alfons H.H. Bongaerts, Julia D.J. Steinberg, Johan R. de Jong, Marjolijn N. Lub-de Hooge, Anouk N.A. van der Horst-Schrivers, Annemiek M.E. Walenkamp, Eelco W. Hoving, Wim J. Sluiter, Bernard A. Zonnenberg, Elisabeth G.E. de Vries and Thera P. Links
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1244-1250; DOI: https://doi.org/10.2967/jnumed.115.167643
  • You have access
    Impact of Appropriate Use on the Estimated Radiation Risk to Men and Women Undergoing Radionuclide Myocardial Perfusion Imaging
    Rami Doukky, Nathan Frogge, Andrew Appis, Kathleen Hayes, George Khoudary, Louis Fogg and Kim A. Williams
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1251-1257; DOI: https://doi.org/10.2967/jnumed.115.167205
  • You have access
    Multi-Atlas–Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas– and CT-Based Attenuation Correction
    Tetsuro Sekine, Ninon Burgos, Geoffrey Warnock, Martin Huellner, Alfred Buck, Edwin E.G.W. ter Voert, M. Jorge Cardoso, Brian F. Hutton, Sebastien Ourselin, Patrick Veit-Haibach and Gaspar Delso
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1258-1264; DOI: https://doi.org/10.2967/jnumed.115.169045

Brief Communications

  • You have access
    Whole-Body Distribution and Radiation Dosimetry of 11C-Elacridar and 11C-Tariquidar in Humans
    Martin Bauer, Matthias Blaickner, Cécile Philippe, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger and Oliver Langer
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1265-1268; DOI: https://doi.org/10.2967/jnumed.116.175182

Continuing Education

  • You have access
    18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications
    Geraldine J. Liao, Amy S. Clark, Erin K. Schubert and David A. Mankoff
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1269-1275; DOI: https://doi.org/10.2967/jnumed.116.175596

Basic Science Investigations

  • You have access
    The Thymidine Phosphorylase Imaging Agent 123I-IIMU Predicts the Efficacy of Capecitabine
    Nobuya Kobashi, Hiroki Matsumoto, Songji Zhao, Shunsuke Meike, Yuki Okumura, Tsutomu Abe, Hiromichi Akizawa, Kazue Ohkura, Ken-ichi Nishijima, Nagara Tamaki and Yuji Kuge
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1276-1281; DOI: https://doi.org/10.2967/jnumed.115.165811
  • You have access
    Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic Tracers
    Svetlana N. Rylova, Beatrice Waser, Luigi Del Pozzo, Roswitha Tönnesmann, Rosalba Mansi, Philipp T. Meyer, Jean Claude Reubi and Helmut R. Maecke
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1282-1288; DOI: https://doi.org/10.2967/jnumed.115.168948
  • You have access
    Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts
    Costanza Santini, Joeri Kuil, Anton Bunschoten, Stefan Pool, Erik de Blois, Yanto Ridwan, Jeroen Essers, Monique R. Bernsen, Fijs W.B. van Leeuwen and Marion de Jong
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1289-1295; DOI: https://doi.org/10.2967/jnumed.115.164970
  • You have access
    Biomarkers for Radiation Pneumonitis Using Noninvasive Molecular Imaging
    Meetha Medhora, Steven Haworth, Yu Liu, Jayashree Narayanan, Feng Gao, Ming Zhao, Said Audi, Elizabeth R. Jacobs, Brian L. Fish and Anne V. Clough
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1296-1301; DOI: https://doi.org/10.2967/jnumed.115.160291
  • You have access
    Serial Quantitative TSPO-Targeted PET Reveals Peak Microglial Activation up to 2 Weeks After an Epileptogenic Brain Insult
    Mirjam Brackhan, Pablo Bascuñana, Johannes M. Postema, Tobias L. Ross, Frank M. Bengel, Marion Bankstahl and Jens P. Bankstahl
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1302-1308; DOI: https://doi.org/10.2967/jnumed.116.172494
  • You have access
    Simultaneous Multiparametric PET/MRI with Silicon Photomultiplier PET and Ultra-High-Field MRI for Small-Animal Imaging
    Guen Bae Ko, Hyun Suk Yoon, Kyeong Yun Kim, Min Sun Lee, Bo Yeun Yang, Jae Min Jeong, Dong Soo Lee, In Chan Song, Seok-ki Kim, Daehong Kim and Jae Sung Lee
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1309-1315; DOI: https://doi.org/10.2967/jnumed.115.170019

Special Contributions

  • You have access
    SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0
    Satoshi Minoshima, Alexander E. Drzezga, Henryk Barthel, Nicolaas Bohnen, Mehdi Djekidel, David H. Lewis, Chester A. Mathis, Jonathan McConathy, Agneta Nordberg, Osama Sabri, John P. Seibyl, Margaret K. Stokes and Koen Van Laere
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1316-1322; DOI: https://doi.org/10.2967/jnumed.116.174615

Book Reviews

  • You have access
    Nuclear Cardiac Imaging: Principles and Applications
    Jin Chul Paeng
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1323; DOI: https://doi.org/10.2967/jnumed.116.178137

Letters to the Editor

  • You have access
    Risk of Breast Cancer in Patients with Thyroid Cancer Receiving 131I Treatment: Is There an Immortal Time Bias?
    Kuan-tin Chen and Yu-Wen Hu
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1324; DOI: https://doi.org/10.2967/jnumed.116.173641
  • You have access
    Reply: Risk of Breast Cancer in Patients with Thyroid Cancer Receiving 131I Treatment: Is There an Immortal Time Bias?
    Chun-Yi Lin, Cheng-Li Lin and Chia-Hung Kao
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1324-1325; DOI: https://doi.org/10.2967/jnumed.116.178152

Errata

  • You have access
    Errata
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1325;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 57 (8)
Journal of Nuclear Medicine
Vol. 57, Issue 8
August 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • How to Achieve Approval of Radiolabeled-PSMA Diagnostic and Therapeutic Agents
  • Molecular Imaging of Inflammation: Current Status
  • PET Amyloid Analyses
  • Highlight
Sign up for alerts

Jump to

  • This Month in JNM
  • SNMMI Newsline
  • Editorials
  • Focus on Molecular Imaging
  • Invited Perspectives
  • Clinical Investigations
  • Brief Communications
  • Continuing Education
  • Basic Science Investigations
  • Special Contributions
  • Book Reviews
  • Letters to the Editor
  • Errata
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire